Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miguel Angel Garcia PerezfiledCriticalMiguel Angel Garcia Perez
Priority to MX2015007502ApriorityCriticalpatent/MX352778B/en
Publication of MX352778BpublicationCriticalpatent/MX352778B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention refers to a novel pharmaceutical composition of modified release for being orally administered in a liquid and/or semisolid form, which contains a therapeutically effective amount of at least a selective enzyme phosphodiesterase inhibitor agent or the pharmaceutically acceptable salts thereof, combined with one or more solvents and/or co-solvents and/or one or more pharmaceutically acceptable salts thereof. The novel composition of the present invention may achieve maximum plasmatic concentrations for a longer period of time, i.e., the release and absorption of sildenafil by the administration of the novel composition is performed in a sustained manner with a gradual absorption.
MX2015007502A2013-01-312013-01-31Pharmaceutical composition with a selective enzyme phosphodiesterase inhibitor in an oral gel form.
MX352778B
(en)